Register to chat with like-minded investors on our interactive forums.
The current HEMO market cap is 18.14M. The company's latest EPS is GBP -0.0050 and P/E is -2.70.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.46M | -2.13M | -2.66M | -5.53M | -5.21M |
| Net Income | -1.45M | -2.08M | -5.1M | -3.98M | -6.69M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 1.05M | 2.67M | 8.52M | 7.09M | 6.11M |
| Total Liabilities | 1.4M | 1.79M | 353k | 3.85M | 3.33M |
| Total Equity | -349k | 876k | 8.17M | 3.24M | 2.78M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -1.2M | -1.8M | -2.63M | -2.9M | -6.11M |
| Investing | 2k | -170k | -939k | -420k | -32k |
| Financing | -39k | 3.21M | 8.78M | -110k | 4.45M |
| Market Cap | 18.14M |
| Price to Earnings Ratio | -2.70 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 15 |
| Price to Book Ratio | 6.51 |
| Dividend Yield | - |
| Shares Outstanding | 1.34B |
| Average Volume (1 week) | 17.32M |
| Average Volume (1 Month) | 12M |
| 52 Week Change | -45.92% |
| 52 Week High | 6.30 |
| 52 Week Low | 1.002 |
| Spread (Intraday) | 0.25 (15.39%) |
| Company Name | Hemogenyx Pharmaceuticals Plc |
| Address |
6th floor london EC3V 0HR |
| Website | https://hemogenyx.com |
| Industry | finance services (6199) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
